Treatment
for malignant mammary tumors includes chemotherapy, radiation therapy and anti-estrogen therapy.
Not exact matches
Mammary Carcinoma Female dogs are at high risk for developing malignant mammary
Mammary Carcinoma Female dogs are at high risk
for developing
malignant mammary mammary tumors.
The chances
for mammary gland
tumors, which are typically
malignant in pets, is greatly reduced
for females.
Approximately 50 percent of
malignant mammary tumors in dogs have receptors
for either estrogen or progesterone.
Despite this, however, spaying a female prior to 2-1/2 years significantly decreases risk
for both benign and
malignant mammary tumors.
Early spaying may therefore, reduce occurrence of
malignant lesions because the procedure removes the source of the hormones that cause some
mammary cells to lose growth control, which puts these dividing cells at high risk
for mutation and
malignant transformation by environmental carcinogens.In fact, recent reports have identified activation of a specific oncogene in a number of canine
mammary tumors.
If the
mammary tumor is
malignant, the surgical site and regional lymph nodes should be checked
for local
tumor recurrence and metastasis, respectively, every 3 months
for the first 12 months after surgery and then every 6 months thereafter.
The role of chemotherapy in cats and dogs with
malignant mammary tumors has not been clearly defined
for all
tumor types but oncologist consultation after surgery is often recommended.
In dogs, the size of
malignant mammary tumors is an important consideration when determining prognosis, both
for local
tumor recurrence and survival time.
Removing the lump
for biopsy is not as bad as it sounds, however, since the first line of treatment of
malignant mammary tumors is surgical removal.
The outcome
for patients with
malignant mammary gland
tumors depends on several factors including
tumor type, histologic grade (appearance of the
tumor cells under the microscope and how similar or dissimilar they are to normal tissues),
tumor size, and
tumor stage (presence of regional and distant metastasis).